---
title: "Silexion Therapeutics (SLXN.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/SLXN.US/norm.md"
symbol: "SLXN.US"
name: "Silexion Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/SLXN.US.md"
datetime: "2026-06-13T17:01:42.036Z"
locales:
  - [en](https://longbridge.com/en/quote/SLXN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SLXN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SLXN.US/norm.md)
---

# Silexion Therapeutics (SLXN.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -8.46 | -14.02 | -28.80 | -38.39 | -161.53 |
| ROE | -755.49% | -368.43% | - | 989.31% | 163.12% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -2.73M | -4.41M | -3.26M | -1.74M | -1.75M |
| 营业利润 | -2.75M | -4.41M | -3.29M | -1.65M | -1.90M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 4.60M | 7.21M | 11.61M | 8.31M | 2.86M |
| 权益乘数 | 15.81 | 2.77 | 1.66 | 3.21 | -0.7177 |
| 每股净资产 | 0.8572 | 8.33 | 22.31 | 44.63 | -323.65 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 2.41M | 5.99M | 9.24M | 6.15M | 1.19M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 403000.00 | 437000.00 | 468000.00 | 534000.00 | 560000.00 |
| 净债务 | -424000.00 | -3.96M | -7.22M | -2.67M | 3.30M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -3.65M | -3.02M | -2.84M | -2.45M | -2.93M |
| 投资现金流 | - | -7000.00 | - | -6000.00 | 0.0000 |
| 融资现金流 | 83000.00 | -221000.00 | 8.62M | 7.43M | 2.18M |
| 自由现金流 | -2.63M | -1.58M | - | -1.64M | -2.18M |
| 现金流充裕率 | - | -150800.00% | - | -349.43% | -1170.40% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | -2000.00 | - | -6000.00 | 0.0000 |